Chinese vaccines set to swarm developing world thestar.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestar.com.my Daily Mail and Mail on Sunday newspapers.
Medical Gel Warmer Device Market.
Chapter 1 to analyze the top manufacturers of Medical Gel Warmer Device, with sales, revenue and price of Medical Gel Warmer Device in 2021-2027.
Chapter 2, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2021-2027.
Chapter 3, to show the global market by regions, with sales, revenue and market share of Medical Gel Warmer Device, for each region, from 2021-2027.
Chapter 4, 5, 6 and 7 to analyze the key regions, with sales, revenue and market share by key countries in these regions.
Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2021-2027.
Vice President Leni Robredo on Sunday, May 9, scored the inoculation of President Duterte with the Sinopharm vaccine despite it not having an emergency use authorization (EUA) from the country’s Food and Drug Administration (FDA).
VP Leni Robredo (Jansen Romero/Manila Bulletin) During her weekly
WHO Approves Emergency Use Listing for China’s Sinopharm CCP Virus Vaccine
The World Health Organization (WHO) on Friday approved China’s state-owned Sinopharm CCP virus vaccine for emergency use for adults over 18.
This comes despite concerns raised by a separate group of WHO experts who said they had “very low confidence” regarding the risk of serious side-effects in some patients.
The Sinopharm jab’s inclusion on the WHO’s emergency use listing allows it to be included in COVAX, a global program that provides vaccines mainly for poor countries.
“This expands the list of [COVID-19] vaccines that COVAX can buy, and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine,” WHO Director-General Tedros Adhanom Ghebreyesus told a briefing.
A medical staff opens a box of the Chinese Sinopharm Covid-19 vaccine. | Robert Atanasovski / AFP
The World Health Organization on Friday approved Chinese vaccine Sinopharm for emergency use in coronavirus patients.
This is the first vaccine developed by a non-Western country to get the global health body’s backing. The WHO had previously only approved the vaccines made by Pfizer, AstraZeneca, Johnson & Johnson and Moderna.
A WHO emergency listing is a signal to national regulators that a product is safe and effective. It also allows the vaccine to be included in COVAX, the World Health Organization’s global initiative to promote equitable vaccine distribution around the world by supplying them to poorer nations.